Sustained S-IgG and S-IgA antibodies to Moderna's mRNA-1273 vaccine in a Sub-Saharan African cohort suggests need for booster timing reconsiderations. (2024)
Attributed to:
Immunomodulation and Vaccines
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.3389/fimmu.2024.1348905
PubMed Identifier: 38357547
Publication URI: http://europepmc.org/abstract/MED/38357547
Type: Journal Article/Review
Volume: 15
Parent Publication: Frontiers in immunology
ISSN: 1664-3224